Related Topics
New drug approved for malaria treatment
The U.S. Food and Drug Administration has approved a new drug aimed at a particular type of malaria that accounts for about 8.5 million infections per year—roughly 15-20% of all malaria cases around the world. The new drug,…
Cuts to HIV funding are slowing down prevention efforts
A new Lancet Commission led by the International AIDS Society raised concerns that a decline in funding has slowed down global efforts to prevent the spread of HIV and warned that the epidemic could flare up once again…
Preparation key to minimize economic losses from epidemics
Nobody knows which pathogen will trigger the next major epidemic, but governments and international organizations should take meaningful steps now to prepare for it in order to mitigate economic losses, according to a trio of researchers from Harvard…
Ebola outbreak in Congo contained, but not yet over
After seven weeks and 28 deaths, the Ebola outbreak in the Democratic Republic of Congo appears to be contained. A recent statement from Oly Ilunga Kalenga, the country’s health minister, noted that all people who were potentially exposed…
What's behind a resurgence of mumps in the United States?
In the early 21st century there was hope that the success of the mumps vaccine in the United States would pave the way for the eventual elimination of the highly contagious disease. But since 2006 there's actually been…
Off the Cuff: The 1918 Flu in 2018
If the 1918 flu virus—which killed between 50 million and 100 million people worldwide—were to appear in 2018 with all its lethality, would we be better or worse off than we were a century ago?
TB unlikely to be eliminated in U.S. anytime soon
But a greater focus on testing and treatment, particularly among immigrants, could speed the disease’s decline, study finds May 21, 2018 – Although tuberculosis (TB) is on the wane in the U.S., there’s little chance that the nation…
Why Public Health? Bobby Brooke Herrera
May 2018 — In our series “Why Public Health?” we ask Harvard T.H. Chan School of Public Health students and alumni to talk about what drew them to the field. After graduating, Bobby Brooke Herrera, PhD ’18,…
Science advocate
Lauren Robertson, PhD ’18, will use her training in the biological sciences to pursue work on the development of a tuberculosis vaccine while mentoring high school students on the side.
Bill Gates makes push for universal flu vaccine, stepped-up efforts to address future pandemics
In conversation with Harvard Chan School Dean Michelle Williams, Gates calls for innovative ideas to combat infectious disease outbreaks May 2, 2018 – Innovative new treatments, improved health care delivery systems, and a coordinated global response are among…
